Actualités 17 avr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 06 mar 2024 H55’s battery system receives approval from the European Union Aviation Safety Agency Valais-based innovator H55’s electric battery system has received approval from the European Union Aviation Safety Agency (EASA).
Actualités 06 mar 2024 Le système de batteries de H55 reçoit l’approbation de l’EASA Le système de batteries électriques de l’innovateur valaisan H55 a reçu l’approbation de l’Agence européenne de la sécurité aérienne (EASA).
News 20 mar 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News 17 avr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Actualités 10 jan 2024 L’essor remarquable de la chimie-pharma dans le canton du Valais Depuis des décennies, le canton du Valais a cultivé une réputation d’excellente dans les domaines de la chimie et de la pharmaceutique, fusionnan...
Actualités 29 jan 2024 L’innovateur en bioproduction Stämm ouvre son centre européen de R&D à Monthey Stämm, une entreprise leader en matière d’innovation dans les technologies de bioprocédés, a annoncé l’ouverture de son nouveau centre de R&D au ...
News 17 jan 2024 Altaroc opens an office in Geneva to accelerate its European expansion Altaroc, a company renowned for democratizing Private Equity in Europe, has recently inaugurated its new office in the heart of Geneva.
News 16 jan 2024 OPEO establishes its first international subsidiary in Lausanne After successfully guiding nearly 150 companies through their transformation journeys in Switzerland, OPEO is taking a significant step by establ...
News 21 fév 2024 Säntis Malt claims another Gold award The Säntis Malt whisky distillery has received a total of five awards for its whiskies at the World Whiskies Awards 2024 in London. The Alpstein ...
News 18 mar 2024 Sedimentum becomes Helpany as it expands into the USA Sedimentum has changed its name to Helpany and is expanding into San Francisco. At the same time, the medtech startup is unveiling its new radar-...
Aktuell 21 fév 2024 Säntis Malt wird erneut mit Gold ausgezeichnet Die Säntis Malt Whisky-Destillerie hat bei den World Whiskies Awards 2024 in London fünf Auszeichnungen für ihre Whiskys erhalten. Der Whisky Edi...
News 25 oct 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 06 nov 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 06 nov 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
Actualités 01 nov 2023 L’usine de Bacthera à Viège entend révolutionner les thérapies microbiomiques A Viège, le centre d’excellence MC4a de Bacthera se prépare à fabriquer des thérapies microbiomiques transformatrices, notamment le SER-109 de Se...